BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions with no assurance regarding its timing, size, or terms.
Proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Offering Details
Shares of common stock (or pre-funded warrants) to be offered by the Company with use of proceeds outlined.
Book-Running Managers
Clear Street and Needham & Company to act as joint book-running managers of the offering.
Registration Statement
Offering made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
Prospectus Supplement
Preliminary prospectus supplement will be filed with the SEC, accessible on the SEC's website.
- BioSig's announcement signifies a strategic move to raise capital through a public offering.
- The use of proceeds, including investment in gold bullion, indicates a diversification strategy for the company's assets.
BioSig Technologies' proposed public offering marks a pivotal moment in its strategic financial planning, aiming to secure funds for growth and expansion opportunities.